Literature DB >> 26576549

Response to the Comments by Dr. Endrikat et al. on the article "Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS)" by Tomohiro Sato, Tsutomu Tamada, Shigeru Watanabe et al. DOI 10.1007/s11547-014-0492-y.

Tomohiro Sato1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26576549     DOI： 10.1007/s11547-015-0592-3

Source DB:  PubMed          Journal:  Radiol Med        ISSN： 0033-8362            Impact factor:   3.469


× No keyword cloud information.
  5 in total

1.  Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.

Authors:  Peter Marckmann; Lone Skov; Kristian Rossen; Anders Dupont; Mette Brimnes Damholt; James Goya Heaf; Henrik S Thomsen
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

2.  Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis.

Authors:  Heather Richmond; Jeffrey Zwerner; Youn Kim; David Fiorentino
Journal:  Arch Dermatol       Date:  2007-08

3.  Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).

Authors:  Tomohiro Sato; Katsuyoshi Ito; Tsutomu Tamada; Akihiko Kanki; Shigeru Watanabe; Hirotake Nishimura; Daigo Tanimoto; Hiroki Higashi; Akira Yamamoto
Journal:  Magn Reson Imaging       Date:  2013-04-30       Impact factor: 2.546

4.  Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.

Authors:  Hubertus Pietsch; Philipp Lengsfeld; Thomas Steger-Hartmann; Andrea Löwe; Thomas Frenzel; Joachim Hütter; Martin A Sieber
Journal:  Invest Radiol       Date:  2009-04       Impact factor: 6.016

5.  Nephrogenic systemic fibrosis.

Authors:  Irwin M Braverman; Shawn Cowper
Journal:  F1000 Med Rep       Date:  2010-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.